— An analyst at Bank of America upgraded the Canadian cannabis company to "buy" from "neutral," noting the "worst looks over" for the beaten-down stock. Canopy's valuation at current levels is "more reasonable" and Wall Street's estimates are "achievable," the analyst said.
Canopy shares are down more than 40% this year.— Johnson & Johnson shares were initiated with an "overweight" rating by an analyst at Cantor Fitzgerald. The analyst said upward profit revisions to the company's pharmaceutical business along with "diminishing headlines" around talc and opioids risk should boost Johnson & Johnson shares.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »